Trials
Search / Trial NCT05645367

Associations of Lipid Measures With Premature Myocardial Infarction: a Cross-sectional Study

Launched by YUE LI · Dec 2, 2022

Trial Information

Current as of January 14, 2025

Unknown status

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • According to the fourth Universal Definition of Myocardial Infarction (2018), the clinical diagnosis was acute myocardial infarction (AMI), including type 1, 2, 3, 4b and 4c.
  • Complete coronary angiography
  • Complete biochemical and blood lipid tests
  • Exclusion Criteria:
  • Recurrent AMI
  • The onset of AMI exceeds 7 days
  • Continuous taking of lipid-lowering drugs ≥ 5 days
  • Patients with missing data

About Yue Li

Yue Li is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on precision medicine and a robust portfolio of clinical studies, Yue Li collaborates with leading healthcare institutions and research organizations to ensure the highest standards of scientific rigor and ethical integrity. The organization prioritizes patient safety and well-being, leveraging cutting-edge methodologies to facilitate the development of new treatments across various therapeutic areas. Yue Li's mission is to contribute to the evolution of healthcare by fostering breakthroughs that address unmet medical needs.

Locations

Harbin, Heilongjiang, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials